DexCom, Inc. (DXCM) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Stock Price

$72.82

-$1.64

(-2.2%)

Day's range

$72.52

$75.29

Consensus Rating

Hold

Based on 28 Analyst Ratings
Consensus Price Target

$81.36

11.73% Upside

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
10/08/2024	RBC Capital	Shagun Singh	$120.00	$68.62	74.88%
08/22/2024	Stifel Nicolaus	Mathew Blackman	$100.00	$72.28	38.35%
08/16/2024	RBC Capital	Shagun Singh	$130.00	$72.36	79.66%
07/29/2024	Barclays	Matt Miksic	$113.00	$64.00	76.56%
07/26/2024	Oppenheimer	Steven Lichtman	$115.00	$107.85	6.63%
07/26/2024	Piper Sandler	Matt O\'Brien	$90.00	$63.22	42.36%
07/26/2024	Canaccord Genuity	William Plovanic	$89.00	$107.85	-17.48%
07/26/2024	RBC Capital	Shagun Singh	$145.00	$63.55	128.17%
07/12/2024	Stifel Nicolaus	Mathew Blackman	$132.00	$112.66	17.17%
06/03/2024	Oppenheimer	Steven Lichtman	$150.00	$115.23	30.17%
05/30/2024	Redburn Partners	Issie Kirby	$130.00	$127.64	1.85%
03/12/2024	RBC Capital	Shagun Singh	$165.00	$134.48	22.7%
10/27/2023	Oppenheimer	Steven Lichtman	$122.00	$88.91	37.22%
10/07/2022	Piper Sandler	Matt O'Brien	$120.00	$95.21	26.04%
07/28/2022	Piper Sandler	Matt O'Brien	$110.00	$86.99	26.45%
05/02/2022	Leerink Partners	Danielle Antalffy	$500.00	$24.79	1916.74%
05/02/2022	Stifel Nicolaus	Mathew Blackman	$520.00	$24.79	1997.41%
01/30/2022	Oppenheimer	Steven Lichtman	$580.00	$26.91	2055.73%
01/18/2022	Wells Fargo	Larry Biegelsen	$575.00	$27.20	2013.82%
01/18/2022	Raymond James	Jayson Bedford	$538.00	$27.20	1877.8%
10/28/2021	Berenberg Bank	Ravi Misra	$630.00	$38.95	1517.43%
10/28/2021	Canaccord Genuity	Kyle Rose	$625.00	$38.95	1504.6%
10/28/2021	UBS	Matthew Taylor	$660.00	$38.95	1594.45%
10/28/2021	Jefferies	Anthony Petrone	$655.00	$38.95	1581.62%
07/29/2021	Stephens	Chris Cooley	$546.00	$32.22	1594.63%
06/08/2021	J.P. Morgan	Robbie Marcus	$450.00	$24.38	1746.01%

DexCom, Inc. Frequently Asked Questions

What analysts cover DexCom, Inc.?

DexCom, Inc. has been rated by research analysts at RBC Capital, Stifel Nicolaus, Barclays, Oppenheimer, Piper Sandler, Canaccord Genuity in the past 90 days.

Get The App

DexCom, Inc. (DXCM) Analyst Forecast

Consensus Rating

Consensus Price Target

Recent Analyst Forecasts and Stock Ratings

DexCom, Inc. Frequently Asked Questions

What analysts cover DexCom, Inc.?

Select an alert type

Setup alert

Premium Content

Log In

Email Verification

Welcome to Stocks.News!

Create Your Account

Email Verification